Back
Monopar Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
MNPR
Monopar Therapeutics, Inc.
Last Price:
$55.15
Seasonality Move:
-19.76%
7 Day Trial
ALL ACCESS PASS
$
7
Monopar Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics, Inc. has on average historically risen by 468.4% based on the past 6 years of stock performance.
-
Monopar Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Monopar Therapeutics, Inc. Stock Undervalued?The current Monopar Therapeutics, Inc. [MNPR] share price is $55.46. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics, Inc. has on average historically risen by 468.4% based on the past 6 years of stock performance.
Monopar Therapeutics, Inc. Stock Rating
Sell
45
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. overpriced?
-
Monopar Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Monopar Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
105.00
52-Week Low:
26.06
Prediction Charts
Market Cap:
370.6M
Price in USD:
55.46
Volume:
181.2K
Beta:
1.42
Technical Analysis
SMA50:
67.72
SMA100:
76.23
SMA200:
57.69
52-Wk Change:
24.13%
Stock Predictions
-
Is Monopar Therapeutics, Inc. stock public?Yes, Monopar Therapeutics, Inc. is a publicly traded company.
-
What is the Monopar Therapeutics, Inc. stock quote today?The Monopar Therapeutics, Inc. stock price is 55.46 USD today.
-
How to buy Monopar Therapeutics, Inc. stock online?You can buy Monopar Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 70.97 | 70.29 | 72.90 | 67.89 |
| Jan-28 | 70.93 | 67.44 | 70.93 | 65.27 |
| Jan-29 | 67.75 | 67.34 | 69.45 | 66.51 |
| Jan-30 | 66.40 | 60.38 | 67.05 | 60.28 |
| Feb-2 | 60.00 | 65.48 | 66.81 | 60.00 |
| Feb-3 | 65.48 | 66.89 | 67.00 | 64.52 |
| Feb-4 | 66.47 | 59.43 | 67.34 | 58.72 |
| Feb-5 | 58.73 | 56.88 | 60.39 | 56.22 |
| Feb-6 | 57.92 | 57.75 | 61.20 | 57.45 |
| Feb-9 | 57.41 | 58.27 | 58.45 | 54.90 |
| Feb-10 | 58.23 | 57.07 | 58.65 | 56.82 |
| Feb-11 | 57.32 | 59.39 | 60.01 | 55.00 |
| Feb-12 | 59.03 | 59.24 | 61.30 | 57.65 |
| Feb-13 | 59.05 | 55.46 | 60.85 | 55.14 |
Monopar Therapeutics, Inc. Earnings
Monopar Therapeutics, Inc. Earnings Report: Per Share Monopar Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics, Inc. Forecast Revenue Growth
Monopar Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.81 per share, and an increase next year of $0.25 per share.
* Monopar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.